Results 171 to 180 of about 1,045,246 (214)
Some of the next articles are maybe not open access.
Estimating the Direct Costs of Illness
The Milbank Memorial Fund Quarterly. Health and Society, 1982about estimating the costs of illness has centered around the relative advantages and disadvantages of the two basic methodologies used or proposed-the "human capital" method as against "willingness to pay." Very briefly, the human capital approach requires estimating the direct costs of illness, i.e., the costs of prevention, detection, treatment, and
openaire +2 more sources
Cost of Illness of Crohn??s Disease
PharmacoEconomics, 2002Crohn's disease is a chronic inflammatory bowel disease of unknown aetiology which affects around 35,000 people in the UK (population 56.8 million). The potential for onset in early adult life, disease chronicity and a need for hospitalisation and surgery mean that the disease can be associated with substantial healthcare costs. Cost-of-illness studies
openaire +2 more sources
Costs of Illness in Cost-Effectiveness Analysis
PharmacoEconomics, 1994Costs of illness are an important input in cost-effectiveness analysis (CEA). Reviews of the literature have found that many CEAs are of low technical quality and fail to take account of costs of illness appropriately. The costs of illness and disease averted by an intervention, indirect costs, and medical care costs in added years of life are topics ...
openaire +2 more sources
The Cost of Cost‐of‐Illness Studies
Medical Journal of Australia, 1993P J, Davey, S R, Leeder
openaire +2 more sources
Annual Costs of Illness versus Lifetime Costs of Illness and Implications of Structural Change
Drug Information Journal, 1988Annual, or prevalence, costs of illness typically measure the costs during a year (the base period) of manifestations of disease that may have had its onset during or any time prior to the base year. Lifetime, or incidence, costs of illness include costs incurred from onset until cure or death, which can extend over many years.
openaire +1 more source
Time to add screening for financial hardship as a quality measure?
Ca-A Cancer Journal for Clinicians, 2021Cathy J Bradley +2 more
exaly